HZ/su (GSK1437173A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HZ/su (GSK1437173A), covering 2017-03-07 to 2017-03-07. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster [Phase 3]